A Comparative Analysis of Amoxicillin and Cefuroxime

Authors

  • Ria Fazulbhoy  Mithibai College, Mumbai University, Mumbai, Maharashtra, India
  • Afrin Khan  Maharashtra Cosmopolitan Education Society's Allana College of Pharmacy, Pune, Maharashtra, India
  • Leona Alison D'souza  St Aloysius Autonomous College, Mangalore, Maharashtra, India
  • Nikhil Dave  Rajiv Gandhi Institute of IT and Biotechnology, Pune, Maharashtra, India
  • Purna Chandu  School of Bioengineering, SRM University, Kattankulathur, Maharashtra, India

DOI:

https://doi.org/10.32628/IJSRST218220

Keywords:

Amoxicillin, Cefuroxime, Antibiotics, Bacterial infections, Renal function.

Abstract

This article is an examination of the Comparative analysis of Amoxicillin and Cefuroxime. The scientific development and subsequent analysis of antibiotics like Amoxicillin and Cefuroximd used to combat bacterial infections such as urinary tract infections, pneumonia, etc. continues to influence the researchers all over the globe today. This article examines the research done and published by researchers and scientists. Consideration of current trends and data in scientific queries and demonstrates further aspects of the comparative analysis of Amoxicillin and Cefuroxime. Additionally, this article explores options for different approaches and applications of Cefuroxime and Amoxicillin such as acute bronchitis, renal functions and tooth enamel defects, acute malnutrition, etc, respectively. This article also highlights the administration, dosages and the various advantages and disadvantages of both the antibiotics Cefuroxime and Amoxicillin, thus giving an in depth, overall comparison of the same.

References

  1. Kalman, D. & Barriere, S. L. Update on Antimicrobial Agents.
  2. Bodey, G. P. & Nance, J. Amoxicillin: In Vitro and Pharmacological Studies. ANTIMICROBIL AGENTS AND CHEMOTHERAPY 358–362 (1972).
  3. Bright, D. A., Gaupp, F. B., Becker, L. J., Schiffert, M. G. & Ryken, T. C. Amoxicillin overdose with gross hematuria. Western Journal of Medicine vol. 150 (1989).
  4. Kalman, D. & Barriere, S. L. Review of the pharmacology, pharmacokinetics, and clinical use of cephalosporins. Texas Heart Institute Journal vol. 17 (1990).
  5. Criteria of drug-induced liver disorders. Report of an International Consensus Meeting. in Journal of Hepatology vol. 11 (1990).
  6. Konishi, K., Suzuki, H., Hayashi, M. & Saruta, T. Pharmacokinetics of cefuroxime axetil in patients with normal and impaired renal function. J. Antimicrob. Chemother. 31, (1993).
  7. Jones, D. P., Gaber, L., Nilsson, G. R., Brewer, E. D. & Stapleton, F. B. Acute Renal Failure Following Amoxicillin Overdose. Clin. Pediatr. (Phila). 32, (1993).
  8. Lode, H., Fassbender, M., Schaberg, T., Borner, K. & Koeppe, P. Comparative Pharmacokinetics of the New Oral Cephalosporins. Drugs 47, (1994).
  9. McLinn, S. E. et al. Comparison of cefuroxime axetil and amoxicillin-clavulanate suspensions in treatment of acute otitis media with effusion in children. Antimicrob. Agents Chemother. 38, (1994).
  10. Henry, D. et al. Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis. Antimicrob. Agents Chemother. 39, (1995).
  11. Belko, J., Urueta, G. & Emre, U. Amoxicillin overdose manifested by hematuria and acute renal failure. Pediatr. Infect. Dis. J. 14, (1995).
  12. Henry, D. et al. Effectiveness of Short-Course Therapy (5 Days) with Cefuroxime Axetil in Treatment of Secondary Bacterial Infections of Acute Bronchitis. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY vol. 39 2528–2534 (1995).
  13. Handsfield, H. H., Clark, H., Wallace, J. F., Holmes, K. K. & Turck, M. Amoxicillin, a new penicillin antibiotic. Antimicrob. Agents Chemother. 3, (1973).
  14. Perry, C. M. & Brogden, R. N. Cefuroxime Axetil: A Review of its Antibacterial Activity, Pharmacokinetic Properties and Therapeutic Efficacy. Drugs vol. 52 (1996).
  15. Maria, V. A. J. & Victorino, R. M. M. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology 26, (1997).
  16. Hautekeete, M. L. et al. HLA association of amoxicillin-clavulanate-induced hepatitis. Gastroenterology 117, (1999).
  17. Aithal, G. P., Rawlins, M. D. & Day, C. P. Clinical diagnostic scale: A useful tool in the evaluation of suspected hepatotoxic adverse drug reactions. J. Hepatol. 33, (2000).
  18. O’Donohue, J. et al. Co-amoxiclav jaundice: Clinical and histological features and HLA class II association. Gut 47, (2000).
  19. Schrag, S. J. et al. Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: A randomized trial. J. Am. Med. Assoc. 286, (2001).
  20. Lucena, M. I., Camargo, R., Andrade, R. J., Perez-Sanchez, C. J. & Cuesta, F. S. D. La. Comparison of two clinical scales for causality assessment in hepatotoxicity. Hepatology 33, (2001).
  21. de Abreu, L. P., Ortiz, R. A. M., de Castro, S. C. & Pedrazzoli, J. HPLC determination of amoxicillin comparative bioavailability in healthy volunteers after a single dose administration. J. Pharm. Pharm. Sci. 6, (2003).
  22. Curtin-Wirt, C. et al. Efficacy of penicillin vs. amoxicillin in children with group A beta hemolytic streptococcal tonsillopharyngitis. Clin. Pediatr. (Phila). 42, (2003).
  23. Fogazzi, G. B., Cantù, M., Saglimbeni, L. & Daudon, M. Amoxycillin, a rare but possible cause of crystalluria. Nephrol. Dial. Transplant. 18, (2003).
  24. Karney, W. W., Turck, M. & Holmes, K. K. Comparative therapeutic and pharmacological evaluation of amoxicillin and ampicillin plus probenecid for the treatment of gonorrhea. Antimicrob. Agents Chemother. 5, (1974).
  25. Hong, L. et al. Association of amoxicillin use during early childhood with developmental tooth enamel defects. Arch. Pediatr. Adolesc. Med. 159, (2005).
  26. Fontana, R. J., Shakil, A. O., Greenson, J. K., Boyd, I. & Lee, W. M. Acute liver failure due to amoxicillin and amoxicillin/clavulanate. Dig. Dis. Sci. 50, (2005).
  27. Geddes, A. M., Klugman, K. P. & Rolinson, G. N. Introduction: historical perspective and development of amoxicillin/clavulanate. Int. J. Antimicrob. Agents 30, (2007).
  28. Muller, A. E. et al. Pharmacokinetics of amoxicillin in maternal, umbilical cord, and neonatal sera. Antimicrob. Agents Chemother. 53, (2009).
  29. Salvo, F., Sarro, A. De, Caputi, A. P. & Polimeni, G. Amoxicillin and amoxicillin plus clavulanate: A safety review. Expert Opinion on Drug Safety vol. 8 (2009).
  30. Kaur, S. P., Rao, R. & Nanda, S. Amoxicillin: A broad spectrum antibiotic. International Journal of Pharmacy and Pharmaceutical Sciences vol. 3 (2011).
  31. Patel, Y., Poddar, A. & Sawant, K. Formulation and characterization of Cefuroxime Axetil nanoemulsion for improved bioavailability. in Journal of Pharmacy and Bioallied Sciences vol. 4 (2012).
  32. P., Y., F., G.-B., H., F., R., T. & S., I. Bioavailability of amoxicilin dissolved in human milk. Journal of Population Therapeutics and Clinical Pharmacology vol. 19 (2012).
  33. Gillies, M. et al. Common harms from amoxicillin: A systematic review and meta-analysis of randomized placebo-controlled trials for any indication. CMAJ 187, (2015).
  34. Hentzien, M. et al. Macroscopic amoxicillin crystalluria. The Lancet vol. 385 (2015).
  35. Foord, R. D. Cefuroxime: human pharmacokinetics. Antimicrob. Agents Chemother. 9, (1976).
  36. Isanaka, S. et al. Routine Amoxicillin for Uncomplicated Severe Acute Malnutrition in Children. N. Engl. J. Med. 374, (2016).
  37. Ianiro, G., Tilg, H. & Gasbarrini, A. Antibiotics as deep modulators of gut microbiota: Between good and evil. Gut 65, (2016).
  38. Tayyeb, J. Z. et al. Amoxicillin modulates apoa-i transcription and secretion, predominantly via PPARα transactivation inhibition. Int. J. Mol. Sci. 20, (2019).
  39. Kleppe, D. M. et al. Amoxicillin-Induced Crystalline Nephropathy Presenting as Ureteral Obstruction. Clin. Pediatr. (Phila). 59, (2020).
  40. Mizera, M. et al. Computer-aided design of cefuroxime axetil/cyclodextrin system with enhanced solubility and antimicrobial activity. Biomolecules 10, (2020).
  41. Spyker, D. A., Rugloski, R. J., Vann, R. L. & O’Brien, W. M. Pharmacokinetics of amoxicillin: dose dependence after intravenous, oral, and intramuscular administration. Antimicrob. Agents Chemother. 11, (1977).
  42. Humbert, G., Spyker, D. A., Fillastre, J. P. & Leroy, A. Pharmacokinetics of amoxicillin: Dosage nomogram for patients with impaired renal function. Antimicrob. Agents Chemother. 15, (1979).
  43. Tartaglione, T. A. & Polk, R. E. Review of the New Second-Generation Cephalosporins: Cefonicid, Ceforanide, and Cefuroxime. Ann. Pharmacother. 19, (1985).
  44. Sjovall, J., Westerlund, D. & Alvan, G. Renal excretion of intravenously infused amoxycillin and ampicillin. Br. J. Clin. Pharmacol. 19, (1985).
  45. Kwatra, B. COLLAGEN SUPPLEMENTATION?: THERAPY FOR SKIN DISORDERS?: A REVIEW. World J. Pharm. Res. 9, 2504–2518 (2020).
  46. Kwatra, B. LOCATOR THEORY FOR ELE-MENTS IN PERIODIC TABLE ‘LEPT’. Glob. J. Pure Appl. Chem. Res. 5, 9–10 (2017).
  47. Kwatra, B. A REVIEW ON POTENTIAL PROPERTIES AND THERAPEUTIC APPLICATIONS OF LYCOPENE. Int. J. Med. Biomed. Stud. 4, 33–44 (2020).
  48. Kwatra, B. A REVIEW ON POTENTIAL PROPERTIES AND THERAPEUTIC APPLICATIONS OF BRANCHED CHAIN AMINO. WORLD J. Pharm. Pharm. Sci. 9, 561–588 (2020).
  49. Kwatra, B. EXPRESSION AND CHARACTERIZATION IN PICHIA PASTORIS BY CLONING OF DELTA 4 DESATURASE FROM ISOCHRYSIS GALBANA. Indian J. Appl. Res. 9, 1–2 (2019).
  50. Kwatra, B. CALCIUM AND IRON ABSORPTION: INVITRO STUDIES. Int. J. Med. Biomed. Stud. 3, 59–61 (2019).
  51. Kwatra, B. HACKING THE BLOOD-BRAIN BARRIER. Eur. J. Biol. Med. Sci. Res. 5, 10–13 (2017).
  52. Kwatra, B. A Review on Potential Properties and Therapeutic Applications of Vitamin D. Int. J. Sci. Res. 9, 682–691 (2020).
  53. Kwatra, B. HYDROQUINONE: A novel growth inhibitor and apoptosis inducer in U-251 MG CELLS. Int. J. Med. Biomed. Stud. 3, 15–16 (2019).
  54. Kwatra, B. Allicin-An After Digestion Antimicrobial Agent. ACTA Sci. Microbiol. 2, 48–51 (2019).
  55. Kwatra, B. A REVIEW ON POTENTIAL PROPERTIES AND THERAPEUTIC APPLICATIONS OF GRAPE SEED EXTRACT. World J. Pharm. Res. 9, 2519–2540 (2020).
  56. Kwatra, B. Studies on People Employed in High Risk Workplace?: Between Genetic Polymorphism for Tumor Necrosis Factor ( TNF- Α ) and Blood Pressure. Int. J. Innov. Res. Technol. 6, 268–270 (2020).
  57. Kwatra, B. Candidate genes of OCD interacts with human retrovirus to form new link in inflammatory hypothesis. Int. J. Sci. Appl. Res. 7, 1–2 (2020).
  58. Kwatra, B. COLLAGEN SUPPLEMENTATION?: THERAPY FOR THE PREVENTION AND TREATMENT OF OSTEOPOROSIS AND OSTEOARTHRITIS?: A REVIEW. WORLD J. Pharm. Pharm. Sci. 9, 589–604 (2020).
  59. Kwatra, B. A Review on Potential Properties and Therapeutic Applications of DHA and EPA. ijppr.humanjournals 16, 140–176 (2019).
  60. Kwatra, B. Tinospora Crispa As A Future Cure For Obesity/Cholesterol. Int. J. Sci. Technol. Res. 6, 340–341 (2017).
  61. Bharat Kwatra. Procuring Natural Dye for Solar Cell Using Leaf Waste. Int. J. Sci. Eng. Res. 7, 46–47 (2019).
  62. Kwatra, B. THE SIMVASTATIN AND DMXAA ON THE CO-CULTURE OF B16.F10 MELANOMA CELLS AND MACROPHAGES SHOWS ANTITUMOR ACTIVITY. World J. Pharm. Res. 8, 1318–1319 (2019).
  63. Kwatra, B. Bioactive-Compounds: alternative to control Candida spp. Int. J. Sci. Res. Rev. 8, 221–223 (2019).
  64. Kwatra, B. Effects of Mineral Separation by Time and Enteric Coating Mechanism for Calcium and Iron Absorption in Mammalia. Int. J. Sci. Res. 8, 1265–1270 (2019).
  65. Kwatra, B. Maprovit 3, 6, 9: Perfect Companion of your Immune System to Fight Corona Virus Hit. Int. J. Sci. Res. 9, 241–241 (2020).
  66. Kwatra, B. MECHANISMS OF PATTERN FORMATION OF FBP17 IN MAST CELLS. Int. J. Adv. Res. 7, 413–414 (2019).
  67. Kwatra, B. A REVIEW ON POTENTIAL PROPERTIES AND THERAPEUTIC APPLICATIONS OF BROMELAIN. www.wjpps.com 8, 488–500 (2019).
  68. Kwatra, B. Holothuroidea (Sea Cucumber): Key to Anti-Aging. Int. J. Sci. Res. 8, 884–884 (2019).

International Journal of Scientific Research in Science and Technology

Downloads

Published

2021-03-30

Issue

Volume 8, Issue 2, March-April-2021

Section

Research Articles

License

Copyright (c) IJSRST

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

[1]
Ria Fazulbhoy, Afrin Khan, Leona Alison D'souza, Nikhil Dave, Purna Chandu "A Comparative Analysis of Amoxicillin and Cefuroxime" International Journal of Scientific Research in Science and Technology(IJSRST), Online ISSN : 2395-602X, Print ISSN : 2395-6011,Volume 8, Issue 2, pp.96-124, March-April-2021. Available at doi : https://doi.org/10.32628/IJSRST218220